Use of sertraline to treat cancer patients

Details Use of sertraline to treat cancer patients Use of sertraline to treat cancer patients

A - Human Necessities

61

K

A61K 31/135 (2006.01)

Patent

CA 2167257

Disclosed is a medicine for treating human cancer patients comprising the compound (1S-cis)-4-(3,4-dichloro- phenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine, also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof.

Affiliated with

Also associated with

Rating

Use of sertraline to treat cancer patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sertraline to treat cancer patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sertraline to treat cancer patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1490691